Results 261 to 270 of about 4,813,932 (329)
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons. [PDF]
Michel M +23 more
europepmc +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Targeted detection of endogenous LINE-1 proteins and ORF2p interactions. [PDF]
Nielsen MI +15 more
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
LINE-1 ribonucleoprotein condensates bind DNA to enable nuclear entry during mitosis. [PDF]
Zernia S +7 more
europepmc +1 more source
Insights into the DNA cleavage mechanism of human LINE‐1 retrotransposon endonuclease
Konstantinos Repanas +4 more
openalex +2 more sources
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Impact of prematurity on LINE-1 promoter methylation. [PDF]
Dos Santos PVBE +12 more
europepmc +1 more source

